NFG
PTCT icon

Next Financial Group’s PTC Therapeutics PTCT Stock Holding History

Next Financial Group’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,300
Closed -$74K – 1834
2015
Q4 		$74K Buy
2,300
+2,100
+1,050% +$61.8K 0.03% 517
2015
Q3 		$5K Hold
200
– – ﹤0.01% 1426
2015
Q2 		$9K Buy
200
+100
+100% +$5.83K ﹤0.01% 1313
2015
Q1 		$6K Hold
100
– – ﹤0.01% 1435
2014
Q4 		$5K Buy
+100
New +$4.4K ﹤0.01% 1506

Other funds holding PTCT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Next Financial Group's PTCT Position: Q1 2016 in Review

Next Financial Group sold out of PTC Therapeutics (PTCT) in Q1 2016, closing a stake of 2,300 shares — an estimated $74K sold.

Next Financial Group first reported a position in PTCT in Q4 2014 and held it in 5 quarters. The position peaked at $74K in Q4 2015. 119 funds tracked by Wall St. Rank hold PTCT as of Q1 2016.

  • Next Financial Group reported no remaining PTC Therapeutics position as of Q1 2016 after selling out during the quarter.
  • Next Financial Group sold 2,300 PTC Therapeutics shares in Q1 2016, an estimated $74K.
  • Next Financial Group first reported a position in PTC Therapeutics in Q4 2014 and held it in 5 quarters.
  • Next Financial Group's PTC Therapeutics position peaked at $74K in Q4 2015.
  • 119 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2016.

Based on Next Financial Group's 13F filing for Q1 2016, filed 20 Apr 2016.